// App-Quantinova.ai

4556 : Efficacy of Adoptive Immunotherapy By Donor Lymphocyte Infusions after Allogeneic Stem Cell Transplantation from Related an Unrelated Donors: A Single Center Retrospective Analysis

Researchers

Presenter

  • Philipp Hemmati

Principal Investigators

  • Christin Vogelsanger

  • Theis Terwey

  • Christian Jehn

  • Lam G. Vuong

  • Igor Wolfgang Blau

  • Olaf Penack

  • Bernd Dorken

  • Renate Arnold

Medical Centers

  • Department of Hematology, Oncology, and Tumor Immunology, Berlin, Germany

  • Department of Hematology, Oncology and Tumor Immunology, Charite University Medicine, Campus Benjamin Franklin, Berlin, Germany

  • Department of Hematology, Oncology and Tumor Immunology, Charite University Medicine, Campus Benjamin Franklin, Berlin, Germany

  • Department Hematology, Oncology and Tumor Immunology, Charite University Hospital, Berlin, Germany

Locations

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • Alpha-thalassemia myelodysplasia syndrome

  • Acute myelocytic leukemia

  • Lymphomas

  • Multiple Myeloma

Biomarkers

  • Breakpoint Cluster Region

  • Cluster of Differentiation 2AP

  • Soluble Complement 5b-9

  • Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein Epsilon

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved